Fromkin Andrew J.
Immunovant, Inc. · Director
Fromkin Andrew J. is listed in filings as Director at Immunovant, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Mar 11, 2025 to May 29, 2026. Reported amounts are shown as $27.6K to $115.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $28k1.4k shares | SellMar 7, 2025 | $19.96 | $38.96 | |
| $129k6.6k shares | SellMar 7, 2025 | $19.52 | $38.96 | |
| $69k2.9k shares | SellDec 1, 2025 | $23.95 | $38.96 | |
| $448k19.4k shares | SellDec 1, 2025 | $23.14 | $38.96 |